FIL Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
FIL Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$7,131,000
-66.1%
481,200
-66.4%
0.01%
-67.9%
Q2 2020$21,065,000
-27.4%
1,432,035
-42.1%
0.03%
-41.7%
Q1 2020$29,013,000
-43.2%
2,471,243
+13.6%
0.05%
-32.4%
Q4 2019$51,116,000
+53.7%
2,175,165
+21.0%
0.07%
+42.0%
Q3 2019$33,249,000
+18.2%
1,797,225
+18.7%
0.05%
+19.0%
Q2 2019$28,138,000
-35.5%
1,513,635
-15.3%
0.04%
-38.2%
Q1 2019$43,658,000
-25.8%
1,786,308
-21.2%
0.07%
-34.6%
Q4 2018$58,828,000
-39.3%
2,267,854
-26.0%
0.10%
-27.3%
Q3 2018$96,956,000
-15.7%
3,063,383
+3.5%
0.14%
-17.3%
Q2 2018$115,003,0002,960,1590.17%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders